[Problem] To provide a phospholipid -linolenic acid composition of consistent quality and having a stable supply of source material, with focus on Torula yeast, which is edible and recognized as safe, in order to resolve issues with omega 3 sources.

[Means for Solving the Problem] As a result of intensive study to resolve the above-noted issues, the inventors of the present invention have discovered that a phospholipid -linolenic acid composition can be obtained using residue of yeast extract extracted from Torula yeast (Candida utilis), for example, which is currently produced in large quantities for application in foods, and so arrived at the present invention.

[Problem] To provide a phospholipid -linolenic acid composition of consistent quality and having a stable supply of source material, with focus on Torula yeast, which is edible and recognized as safe, in order to resolve issues with omega 3 sources.

[Means for Solving the Problem] As a result of intensive study to resolve the above-noted issues, the inventors of the present invention have discovered that a phospholipid -linolenic acid composition can be obtained using residue of yeast extract extracted from Torula yeast (Candida utilis), for example, which is currently produced in large quantities for application in foods, and so arrived at the present invention.

A nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease is disclosed. The nutritional composition comprises casein protein, vitamin K in a ratio of vitamin K1:vitamin K2 being between 3:1 to 1:3 and the vitamin K providing between 3.5-20 g/100 kcal of the nutritional composition, vitamin D and alpha-linolenic acid. A pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product or a combination thereof comprising the nutritional composition is also disclosed. A method for improving musculoskeletal health is also disclosed.

A nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease is disclosed. The nutritional composition comprises casein protein, vitamin K in a ratio of vitamin K1:vitamin K2 being between 3:1 to 1:3 and the vitamin K providing between 3.5-20 g/100 kcal of the nutritional composition, vitamin D and alpha-linolenic acid. A pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product or a combination thereof comprising the nutritional composition is also disclosed. A method for improving musculoskeletal health is also disclosed.

The present invention relates to an age-tailored nutritional composition system comprising at least one nutritional composition A that is administered to an infant from birth and until 3-6 months of life of said infant, at least one nutritional composition B that is administered to an infant from 3-6 months and until 1 year of life of said infant, at least one nutritional composition C that is administered after the first year of life of the young child, and wherein the amount of protein of the different nutritional compositions A, B, C decreases with the sequence of administration. The present invention furthermore relates to the uses of said nutritional composition system.

The present invention relates to an age-tailored nutritional composition system comprising at least one nutritional composition A that is administered to an infant from birth and until 3-6 months of life of said infant, at least one nutritional composition B that is administered to an infant from 3-6 months and until 1 year of life of said infant, at least one nutritional composition C that is administered after the first year of life of the young child, and wherein the amount of protein of the different nutritional compositions A, B, C decreases with the sequence of administration. The present invention furthermore relates to the uses of said nutritional composition system.

The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.

The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.

A maternal supplement or human milk fortifier composition comprising at least one nutrientselected in the list consisting of: ALA, DHA, EPA, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said maternal supplement or human milk fortifier composition is specifically tailored or adapted for a woman who has delivered via C-section who is breast feeding. Said maternal supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a woman who has delivered via C-section and promote associated health benefits.

A maternal supplement or human milk fortifier composition comprising at least one nutrientselected in the list consisting of: ALA, DHA, EPA, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said maternal supplement or human milk fortifier composition is specifically tailored or adapted for a woman who has delivered via C-section who is breast feeding. Said maternal supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a woman who has delivered via C-section and promote associated health benefits.